Clinical Trial Update: Study of SCY-635, Pegasys and Copegus in Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial of SCY-635 in combination with Pegasys and Copegus for Hepatitis C has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• SCY-635 (SCY-635)

Snippet

Sponsor: Scynexis, Inc. | Conditions: Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-08-18